BioIVT logo

BioIVT

ELEVATING SCIENCE

Last updated: . For recent data, use our API.

Overview

BioIVT, formerly BioreclamationIVT, is a leading global provider of high-quality biological specimens and value-added services. We specialize in control and disease state samples including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples.

Our Research Services team works collaboratively with clients to provide in vitro hepatic modeling solutions. And as the world’s premier supplier of ADME-Tox model systems, including hepatocytes and subcellular fractions, BioIVT enables scientists to better understand the pharmacokinetics and drug metabolism of newly discovered compounds and the effects on disease processes. By combining our technical expertise, exceptional customer service, and unparalleled access to biological specimens, BioIVT serves the research community as a trusted partner in ELEVATING SCIENCE®.

Funding rounds

Disclosed funding: $45M across 4 rounds. Latest: Venture Round, 8 Jun 2026.

3 rounds have an undisclosed amount, not included in the total.

DateTypeAmount
8 Jun 2026Venture RoundNot disclosed
More funding rounds via API
Get company data via API

Get company records through the Enrich Layer API. These pages show previews only.

Office locations

Latest videos from BioIVT on YouTube

  • ADME 101: Reaction Phenotyping Studies
  • From Biology to Decisions: Designing NAM Workflows to Build Scientific and Translational Confidence
  • Evolving Oncology Biomarker Discovery–Why Multi-Omic Strategies Are Reshaping Translational Research
  • Evaluating DDI Risk in Emerging Drug Modalities
View channel

BioIVT FAQ

As of 2026-10-04, BioIVT has 361 employees, based on the Enrich Layer count of LinkedIn profiles that list BioIVT as their current employer. Its LinkedIn company size band is 501 to 1,000.
As of 2026-10-04, BioIVT is headquartered in Woodbury, New York, US.
BioIVT was founded in 1981.
As of 2026-10-04, BioIVT is classified in the Biotechnology Research industry.